Ion Beam Applications (IOBCF) Stock Price, News & Analysis

Company Overview

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Key Stats

• Today's Range: $13.75 to $13.75
• 50-Day Range: $13.50 to $14.98
• 52-Week Range: $10.35 to $15.75
• Volume: 700 shs
• Average Volume: 1,675 shs
• Market Capitalization: N/A
• P/E Ratio: 162.21
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ion Beam Applications Stock Analysis - MarketRank™

Ion Beam Applications scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ion Beam Applications.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ion Beam Applications is 162.21, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 111.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ion Beam Applications is 162.21, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 88.83.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ion Beam Applications has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Ion Beam Applications has recently decreased by 12.26%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ion Beam Applications does not currently pay a dividend.

Dividend Growth

Ion Beam Applications does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ion Beam Applications has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Ion Beam Applications has recently decreased by 12.26%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.90

News Sentiment

Ion Beam Applications has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Ion Beam Applications this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ion Beam Applications insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 14.86% of the stock of Ion Beam Applications is held by institutions.

IOBCF Stock Analysis - Frequently Asked Questions

How have IOBCF shares performed this year?

Ion Beam Applications' stock was trading at $13.85 on January 1st, 2025. Since then, IOBCF stock has decreased by 0.7% and is now trading at $13.75.
View the best growth stocks for 2025 here.

How do I buy shares of Ion Beam Applications?

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 1/22/2025
• Next Earnings (Estimated): 3/19/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IOBCF
• CUSIP: N/A
• CIK: N/A
• Web: www.iba-worldwide.com
• Phone: (321) 047-5811
• Fax: N/A
• Employees: 2,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 162.21
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A